Complexo Hospitalario Universitario de Santiago
Centro de atención
Mayo Clinic
Rochester, Estados UnidosPublicacións en colaboración con investigadores/as de Mayo Clinic (50)
2024
2023
-
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance
Arthritis Care and Research, Vol. 75, Núm. 1, pp. 53-60
-
Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom
Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245
-
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review
The Journal of rheumatology, Vol. 50, Núm. 6, pp. 789-798
-
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
eClinicalMedicine, Vol. 58
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
2022
-
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86
-
Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
ACR Open Rheumatology, Vol. 4, Núm. 11, pp. 948-953
-
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978
-
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry
ACR Open Rheumatology, Vol. 4, Núm. 10, pp. 872-882
-
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
The Lancet Rheumatology, Vol. 4, Núm. 9, pp. e603-e613
-
Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))
Pharmacopsychiatry
-
Galactose epimerase deficiency: lessons from the GalNet registry
Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 331
-
Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
Heart Rhythm, Vol. 19, Núm. 2, pp. 228-234
-
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review
Rheumatology (Oxford, England), Vol. 61, Núm. 12, pp. 4603-4618
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
Variations in management of A3 and A4 cervical spine fractures as designated by the AO Spine Subaxial Injury Classification System
Journal of Neurosurgery: Spine, Vol. 36, Núm. 1, pp. 99-112